P

Protagonist Therapeutics
D

PTGX

56.284
USD
1.12
(2.03%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
72
حجم السوق
3,488,592,355
أصول ذات صلة
B
BEAM
-0.890
(-4.10%)
20.840 USD
C
CRSP
-1.010
(-1.56%)
63.750 USD
E
EDIT
-0.18000
(-5.73%)
2.96000 USD
GILD
GILD
-3.200
(-2.75%)
113.010 USD
MRNA
MRNA
-0.215
(-0.63%)
33.930 USD
N
NTLA
-0.485
(-3.57%)
13.110 USD
VRTX
VRTX
-8.76
(-1.87%)
460.82 USD
المزيد
الأخبار المقالات

العنوان: Protagonist Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Itspipeline products include Rusfertide (PTG-300) and JNJ-2113.